Global Arthritis Drug Market Research Report 2019

Table of Contents

Executive Summary

1 Arthritis Drug Market Overview

• 1.1 Product Overview and Scope of Arthritis Drug
• 1.2 Arthritis Drug Segment by Type
  • 1.2.1 Global Arthritis Drug Production Growth Rate Comparison by Type (2014-2025)
  • 1.2.2 Synthetic DMARDs
  • 1.2.3 Biological DMARDs
  • 1.2.4 NSAIDs
  • 1.2.5 Corticosteroids
  • 1.2.6 Analgesics
• 1.3 Arthritis Drug Segment by Application
  • 1.3.1 Arthritis Drug Consumption Comparison by Application (2014-2025)
  • 1.3.2 Retail Pharmacies
  • 1.3.3 Hospital Pharmacies
  • 1.3.4 Drug Stores
  • 1.3.5 E-Commerce
• 1.4 Global Arthritis Drug Market by Region
  • 1.4.1 Global Arthritis Drug Market Size Region
  • 1.4.2 North America Status and Prospect (2014-2025)
  • 1.4.3 Europe Status and Prospect (2014-2025)
  • 1.4.4 China Status and Prospect (2014-2025)
  • 1.4.5 Japan Status and Prospect (2014-2025)
• 1.5 Global Arthritis Drug Market Size
  • 1.5.1 Global Arthritis Drug Revenue (2014-2025)
  • 1.5.2 Global Arthritis Drug Production (2014-2025)

2 Global Arthritis Drug Market Competition by Manufacturers

• 2.1 Global Arthritis Drug Production Market Share by Manufacturers (2014-2019)
• 2.2 Global Arthritis Drug Revenue Share by Manufacturers (2014-2019)
• 2.3 Global Arthritis Drug Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers Arthritis Drug Production Sites, Area Served, Product Types
• 2.5 Arthritis Drug Market Competitive Situation and Trends
  • 2.5.1 Arthritis Drug Market Concentration Rate
  • 2.5.2 Arthritis Drug Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global Arthritis Drug Production Market Share by Regions

• 3.1 Global Arthritis Drug Production Market Share by Regions
• 3.2 Global Arthritis Drug Revenue Market Share by Regions (2014-2019)
• 3.3 Global Arthritis Drug Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America Arthritis Drug Production
  • 3.4.1 North America Arthritis Drug Production Growth Rate (2014-2019)
  • 3.4.2 North America Arthritis Drug Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe Arthritis Drug Production
  • 3.5.1 Europe Arthritis Drug Production Growth Rate (2014-2019)
  • 3.5.2 Europe Arthritis Drug Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China Arthritis Drug Production (2014-2019)
  • 3.6.1 China Arthritis Drug Production Growth Rate (2014-2019)
  • 3.6.2 China Arthritis Drug Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan Arthritis Drug Production (2014-2019)
  • 3.7.1 Japan Arthritis Drug Production Growth Rate (2014-2019)
  • 3.7.2 Japan Arthritis Drug Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Arthritis Drug Consumption by Regions

• 4.1 Global Arthritis Drug Consumption by Regions
• 4.2 North America Arthritis Drug Consumption (2014-2019)
• 4.3 Europe Arthritis Drug Consumption (2014-2019)
• 4.4 China Arthritis Drug Consumption (2014-2019)
• 4.5 Japan Arthritis Drug Consumption (2014-2019)

5 Global Arthritis Drug Production, Revenue, Price Trend by Type

• 5.1 Global Arthritis Drug Production Market Share by Type (2014-2019)
• 5.2 Global Arthritis Drug Revenue Market Share by Type (2014-2019)
• 5.3 Global Arthritis Drug Price by Type (2014-2019)
• 5.4 Global Arthritis Drug Production Growth by Type (2014-2019)

6 Global Arthritis Drug Market Analysis by Applications

• 6.1 Global Arthritis Drug Consumption Market Share by Application (2014-2019)
• 6.2 Global Arthritis Drug Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Arthritis Drug Business

• 7.1 Novartis
  • 7.1.1 Novartis Arthritis Drug Production Sites and Area Served
  • 7.1.2 Arthritis Drug Product Introduction, Application and Specification
  • 7.1.3 Novartis Arthritis Drug Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 Eli Lilly
  • 7.2.1 Eli Lilly Arthritis Drug Production Sites and Area Served
  • 7.2.2 Arthritis Drug Product Introduction, Application and Specification
  • 7.2.3 Eli Lilly Arthritis Drug Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 Celltrion
  • 7.3.1 Celltrion Arthritis Drug Production Sites and Area Served
  • 7.3.2 Arthritis Drug Product Introduction, Application and Specification
  • 7.3.3 Celltrion Arthritis Drug Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 F. Hoffmann-La Roche
  • 7.4.1 F. Hoffmann-La Roche Arthritis Drug Production Sites and Area Served
  • 7.4.2 Arthritis Drug Product Introduction, Application and Specification
  • 7.4.3 F. Hoffmann-La Roche Arthritis Drug Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.5 Pfizer
  • 7.5.1 Pfizer Arthritis Drug Production Sites and Area Served
  • 7.5.2 Arthritis Drug Product Introduction, Application and Specification
  • 7.5.3 Pfizer Arthritis Drug Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.5.4 Main Business and Markets Served
• 7.6 Johnson & Johnson
  • 7.6.1 Johnson & Johnson Arthritis Drug Production Sites and Area Served
  • 7.6.2 Arthritis Drug Product Introduction, Application and Specification
  • 7.6.3 Johnson & Johnson Arthritis Drug Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.6.4 Main Business and Markets Served
• 7.7 GSK
  • 7.7.1 GSK Arthritis Drug Production Sites and Area Served
  • 7.7.2 Arthritis Drug Product Introduction, Application and Specification
  • 7.7.3 GSK Arthritis Drug Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.7.4 Main Business and Markets Served

8 Arthritis Drug Manufacturing Cost Analysis

• 8.1 Arthritis Drug Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Arthritis Drug
• 8.4 Arthritis Drug Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 Arthritis Drug Distributors List
• 9.3 Arthritis Drug Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global Arthritis Drug Market Forecast

• 11.1 Global Arthritis Drug Production, Revenue Forecast
  • 11.1.1 Global Arthritis Drug Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global Arthritis Drug Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global Arthritis Drug Price and Trend Forecast (2019-2025)
• 11.2 Global Arthritis Drug Production Forecast by Regions (2019-2025)
  • 11.2.1 North America Arthritis Drug Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe Arthritis Drug Production, Revenue Forecast (2019-2025)
  • 11.2.3 China Arthritis Drug Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan Arthritis Drug Production, Revenue Forecast (2019-2025)
• 11.3 Global Arthritis Drug Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America Arthritis Drug Consumption Forecast (2019-2025)
  • 11.3.2 Europe Arthritis Drug Consumption Forecast (2019-2025)
  • 11.3.3 China Arthritis Drug Consumption Forecast (2019-2025)
  • 11.3.4 Japan Arthritis Drug Consumption Forecast (2019-2025)
• 11.4 Global Arthritis Drug Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global Arthritis Drug Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List